Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells

Molecular and Cellular Proteomics

Volumn 11, Issue 11, 2012, Pages 1320-1339

  Chang, Ying Hua ^a   Lee, Shu Hui ^a   Liao, I Chuang ^b   Huang, Shin Huei ^a   Cheng, Hung Chi ^a   Liao, Pao Chi ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; DIPEPTIDYL PEPTIDASE IV; FIBRONECTIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CAPILLARY ENDOTHELIUM; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL SURFACE; CELL SUSPENSION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CAPILLARY; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; QUANTITATIVE ANALYSIS;

ADENOCARCINOMA; ALPHA 1-ANTITRYPSIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; POLYMERIZATION; REPRODUCIBILITY OF RESULTS;

EID: 84869232807     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.017384     Document Type: Article

References (107)

1. Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell. 100, 57-70 (Pubitemid 30046295)
2. Sugiura, H., Yamada, K., Sugiura, T., Hida, T., and Mitsudomi, T. (2008) Predictors of survival in patients with bone metastasis of lung cancer. Clin. Orthop. Relat. Res. 466, 729-736
3. D'Addario, G., Früh, M., Reck, M., Baumann, P., Klepetko, W., Felip, E., and ESMO Guidelines Working Group. (2010) Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 21, 116-119
4. Woodhouse, E. C., Chuaqui, R. F., and Liotta, L. A. (1997) General mechanisms of metastasis. Cancer 80, 1529-1537 (Pubitemid 27444024)
5. Box, G. M., and Eccles, S. A. (2011) Simple experimental and spontaneous metastasis assays in mice. Methods Mol Biol. 769, 311-329
6. Khanna, C., and Hunter, K. (2005) Modeling metastasis in vivo. Carcinogenesis 26, 513-523 (Pubitemid 41214139)
7. Fidler, I. J., (2006) Models for spontaneous metastasis. Cancer Res. 66, 9787
8. Tjalsma, H., Bolhuis, A., Jongbloed, J. D., Bron, S., and van Dijl, J. M. (2000) Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol. Mol. Biol. Rev. 64, 515-547
9. Volmer, M. W., Stühler, K., Zapatka, M., Schöneck, A., Klein-Scory, S., Schmiegel, W., Meyer, H. E., and Schwarte-Waldhoff, I. (2005) Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer. Proteomics. 5, 2587-2601 (Pubitemid 40966486)
10. Simpson, R. J., Lim, J. W., Moritz, R. L., and Mathivanan, S. (2009) Exosomes: proteomic insights and diagnostic potential. Expert Rev. Proteomics 6, 267-283
11. Mathivanan, S., Lim, J. W., Tauro, B. J., Ji, H., Moritz, R. L., and Simpson, R. J. (2010) Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell. Proteomics 9, 197-208
12. Liotta, L. A., and Kohn, E. C. (2001) The microenvironment of the tumour-host interface. Nature 411, 375-379
13. Nomura, T., and Katunuma, N. (2005) Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J. Med. Invest. 52, 1-9
14. Lane, T. F., and Sage, E. H. (1994) The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8, 163-173 (Pubitemid 24067139)
15. De, S., Chen, J., Narizhneva, N. V., Heston, W., Brainard, J., Sage, E. H., and Byzova, T. V. (2003) Molecular pathway for cancer metastasis to bone. J. Biol. Chem. 278, 39044-39050 (Pubitemid 37221807)
16. Chang, Y. H., Wu, C. C., Chang, K. P., Yu, J. S., Chang, Y. C., and Liao, P. C. (2009) Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma. J. Proteome Res. 8, 5465-5474
17. Grant, S. G., and Blackstock, W. P. (2001) Proteomics in neuroscience: from protein to network. J. Neurosci. 21, 8315-8318 (Pubitemid 33051427)
18. Wu, C. C., Hsu, C. W., Chen, C. D., Yu, C. J., Chang, K. P., Tai, D. I., Liu, H. P., Su, W. H., Chang, Y. S., and Yu, J. S. (2010) Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell. Proteomics 9, 1100-1117
19. Grønborg, M., Kristiansen, T. Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O. N., Hruban, R. H., Goggins, M. G., Maitra, A., and Pandey, A. (2006) Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteomics 5, 157-171 (Pubitemid 43169348)
20. Xue, H., Lü, B., Zhang, J., Wu, M., Huang, Q., Wu, Q., Sheng, H., Wu, D., Hu, J., and Lai, M. (2010) Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J. Proteome Res. 9, 545-555
21. Sintiprungrat, K., Singhto, N., Sinchaikul, S., Chen, S. T., and Thongboonkerd, V. (2010) Alterations in cellular proteome and secretome upon differentiation from monocyte to macrophage by treatment with phorbol myristate acetate: insights into biological processes. J. Proteomics 73, 602-618
22. Keller, M., Rüegg, A., Werner, S., and Beer, H. D. (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818-831 (Pubitemid 351312798)
23. West, G. M., Tucker, C. L., Xu, T., Park, S. K., Han, X., Yates, J. R. 3rd, and Fitzgerald, M. C. (2010) Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements. Proc. Natl. Acad. Sci. U.S.A. 107, 9078-9082
24. Yang, P. C., Luh, K. T., Wu, R., and Wu, C. W. (1992) Characterization of the mucin differentiation in human lung adenocarcinoma cell lines. Am. J. Respir. Cell Mol. Biol. 7, 161-171
25. Kao, Y. R., Shih, J. Y., Wen, W. C., Ko, Y. P., Chen, B. M., Chan, Y. L., Chu, Y. W., Yang, P. C., Wu, C. W., and Roffler, S. R. (2003) Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin. Cancer Res. 9, 2807-2816
26. Shih, J. Y., Yang, S. C., Hong, T. M., Yuan, A., Chen, J. J., Yu, C. J., Chang, Y. L., Lee, Y. C., Peck, K., Wu, C. W., and Yang, P. C. (2001) Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J. Natl. Cancer Inst. 93, 1392-1400 (Pubitemid 32936816)
27. Wang, C. C., Tsai, M. F., Hong, T. M., Chang, G. C., Chen, C. Y., Yang, W. M., Chen, J. J., and Yang, P. C. (2005) The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene 24, 4081-4093 (Pubitemid 40897054)
28. Kuo, J. C., Wang, W. J., Yao, C. C., Wu, P. R., and Chen, R. H. (2006) The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway. J. Cell Biol. 172, 619-631
29. Wu, H. Y., Chang, Y. H., Chang, Y. C., and Liao, P. C. (2009) Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry. J. Proteome Res. 8, 380-389
30. Chiu, K. H., Chang, Y. H., Wu, Y. S., Lee, S. H., and Liao, P. C. (2011) Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling. J. Proteome Res. 10, 1110-1125
31. Goldstein, N. S., Ferkowicz, M., Odish, E., Mani, A., and Hastah, F. (2003) Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am. J. Clin. Pathol. 120, 86-92 (Pubitemid 37046374)
32. Cheng, H. C., Abdel-Ghany, M., Elble, R. C., and Pauli, B. U. (1998) Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J. Biol. Chem. 273, 24207-24215 (Pubitemid 28435768)
33. Cheng, H. C., Abdel-Ghany, M., and Pauli, B. U. (2003) A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J. Biol. Chem. 278, 24600-24607 (Pubitemid 37548613)
34. Han, C. L., Chen, J. S., Chan, E. C., Wu, C. P., Yu, K. H., Chen, K. T., Tsou, C. C., Tsai, C. F., Chien, C. W., Kuo, Y. B., Lin, P. Y., Yu, J. S., Hsueh, C., Chen, M. C., Chan, C. C., Chang, Y. S., and Chen, Y. J. (2011) An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Mol. Cell. Proteomics 10, 10.1074/mcp.M110.003087
35. Holm, S. (1979) A simple sequentially rejective multiple test procedure. Scand. J. Statist. 6, 65-70
36. Thomas N. P., Søren, B., Gunnar, V. H., and Henrik, N. (2011) SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods 8, 785-786
37. Bendtsen, J. D., Jensen, L. J., Blom, N., Von Heijne, G., and Brunak, S. (2004) Feature based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17, 349-356 (Pubitemid 39093515)
38. Möller, S., Croning, M. D., and Apweiler, R. Evaluation of methods for the prediction of membrane spanning regions. (2001) Bioinformatics 17, 646-653 (Pubitemid 32707587)
39. Mathivanan, S., and Simpson, R. J. (2009) ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9, 4997-5000
40. Mathivanan, S., Ji, H., and Simpson, R. J. (2010) Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73, 1907-1920
41. Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D., Adkins, J. N., Pounds, J. G., Fagan, R., and Lobley, A. (2004) The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 3, 311-326
42. Muthusamy, B., Hanumanthu, G., Reshmi, R., Sriranjini, S., Suresh, S., Rekha, B., Srinivas, D., Karthick, L., Vrushabendra, B. M., Sharma, S., Mishra, G., Rashmi, B. P., Kadekar, S., Chatterjee, P., Mangala, K. S., Shivashankar, H. N., Chandrika, K. N., Deshpande, N., Suresh, M., Kannabiran, N., Niranjan, V., Nalli, A., Prasad, T. S. K., Arun, K. S., Reddy, R., Chandran, S., Jadhav, T., Julie, D., Mahesh, M., John, S. L., Palvankar, K., Sudhir, D., Bala, P., Jithesh, M. K., Rashmi, N. S., Vishnupriya, G., Dhar, K., Reshma, S., Chaerkady, R., Prasad, C. K. Gandhi, T. K. B., Harsha, H. C., Mohan, S. S., Deshpande, K. S., Sarker, M., and Pandey, A. (2005) Plasma proteome database as a resource for proteomics research. Proteomics 5, 3531-3536 (Pubitemid 41192058)
43. Lee, M., Fridman, R., and Mobashery, S. (2004) Extracellular proteases as targets for treatment of cancer metastases. Chem. Soc. Rev. 33, 401-409 (Pubitemid 39456998)
44. Jee, B. K., Park, K. M., Surendran, S., Lee, W. K., Han, C. W., Kim, Y. S., and Lim, Y. (2006) KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line. Biochem. Biophys. Res. Commun. 342, 655-661 (Pubitemid 43289040)
45. Deryugina, E. I., and Quigley, J. P. (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25, 9-34 (Pubitemid 43723979)
46. Hunter, K. W., Crawford, N. P., and Alsarraj, J. (2008) Mechanisms of metastasis. Breast Cancer Research 10, S2
47. Friedl, P., and Wolf, K. (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362-374 (Pubitemid 37328856)
48. Huang, L., Cheng, H. C., Isom, R., Chen, C. S., Levine, R. A., and Pauli, B. U. (2008) Protein kinase Cepsilon mediates polymeric fibronectin assembly on the surface of blood-borne rat breast cancer cells to promote pulmonary metastasis. J. Biol. Chem. 283, 7616-7627
49. Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., and Green, M. R. (2008) Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132, 363-374 (Pubitemid 351191995)
50. Samani, A. A., Yakar, S., LeRoith, D., and Brodt, P. (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr. Rev. 28, 20-47 (Pubitemid 46220849)
51. Chang, C. C., Shih, J. Y., Jeng, Y. M., Su, J. L., Lin, B. Z., Chen, S. T., Chau, Y. P., Yang, P. C., and Kuo, M. L. (2004) Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J. Natl. Cancer Inst. 96, 364-375
52. Böttger, A., Strasser, D., Alexandrova, O., Levin, A., Fischer, S., Lasi, M., Rudd, S., and David, C. N. (2006) Genetic screen for signal peptides in Hydra reveals novel secreted proteins and evidence for non-classical protein secretion. Eur. J. Cell Biol. 85, 1107-1117 (Pubitemid 44317606)
53. Bendtsen, J. D., Jensen, L. J., Blom, N., Von Heijne, G., and Brunak, S. (2004) Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17, 349-356 (Pubitemid 39093515)
54. Mor-Vaknin, N., Punturieri, A., Sitwala, K., and Markovitz, D. M. (2003) Vimentin is secreted by activated macrophages. Nat. Cell Biol. 5, 59-63 (Pubitemid 36054330)
55. Nickel, W. (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270, 2109-2119
56. Théry, C., Ostrowski, M., and Segura, E. (2009) Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593
57. Clayton, A., and Mason, M. D. (2009) Exosomes in tumour immunity. Curr. Oncol. 16, 46-49
58. Andre, F., Schartz, N. E., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., Tursz, T., Amigorena, S., Raposo, G., Angevin, E., and Zitvogel, L. (2002) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360, 295-305 (Pubitemid 34874721)
59. Park, J. E., Tan, H. S., Datta, A., Lai, R. C., Zhang, H., Meng, W., Lim, S. K., and Sze, S. K. (2010) Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol. Cell. Proteomics 9, 1085-1099
60. Gettins, P. G. (2002) Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4804
61. Kumar, V., Abbas, A. K., and Fausto, N. (2005) Robbin and Cotran Pathological Basis of Disease (7th ed.) Elsevier/Saunders, 911-912. ISBN 978-0-7216-0187-3
62. Stoller, J. K., and Aboussouan, L. S. (2005) Alpha1-antitrypsin deficiency. Lancet 365, 2225-2236
63. Yang, P., Sun, Z., Krowka, M. J., Aubry, M. C., Bamlet, W. R., Wampfler, J. A., Thibodeau, S. N., Katzmann, J. A., Allen, M. S., Midthun, D. E., Marks, R.S., and de Andrade, M. (2008) Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch. Intern. Med. 168, 1097-1103 (Pubitemid 351749227)
64. Gross, V., Geiger, T., Tran-Thi, T. A., Gauthier, F., and Heinrich, P. C. (1982) Biosynthesis and secretion of alpha 1-antitrypsin in primary cultures of rat hepatocytes. Characterization of differently glycosylated intracellular and extracellular forms. Eur J Biochem. 129, 317-323 (Pubitemid 13153727)
65. Bolmer, S., and Kleinerman, J. (1986) Isolation and characterization of alpha 1-antitrypsin in PAS-positive hepatic granules from rats with experimental alpha 1-antitrypsin deficiency. Am J Pathol. 123, 377-389 (Pubitemid 16072538)
66. Alam, S., Li, Z., Janciauskiene, S., and Mahadeva, R. (2011) Oxidation of Z α1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema. Am. J. Respir. Cell Mol. Biol. 245, 261-269
67. Purkayastha, P., Klemke, J. W., Lavender, S., Oyola, R., Cooperman, B. S., and Gai, F. (2005) Alpha 1-antitrypsin polymerization: a fluorescence correlation spectroscopic study. Biochemistry 44, 2642-2649 (Pubitemid 40279568)
68. Salahuddin, P. (2010) Genetic variants of alpha1-antitrypsin. Curr Protein Pept Sci. 11, 101-117
69. Gooptu, B., Miranda, E., Nobeli, I., Mallya, M., Purkiss, A., Brown, S. C., Summers, C., Phillips, R. L., Lomas, D. A., and Barrett, T. E. (2009) Crystallographic and cellular characterisation of two mechanisms stabilising the native fold of alpha1-antitrypsin: implications for disease and drug design. J. Mol. Biol. 387, 857-868
70. El-Akawi, Z. J., Al-Hindawi, F. K., and Bashir, N. A. (2008) Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients. Neuroendocrinol. Lett. 29, 482-484
71. El-Akawi, Z. J., Abu-Awad, A. M., Sharara, A. M., and Khader, Y. (2010) The importance of alpha-1 antitrypsin (alpha1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients. Neuroendocrinol. Lett. 31, 113-116
72. Comunale, M. A., Rodemich-Betesh, L., Hafner, J., Wang, M., Norton, P., Di Bisceglie, A. M., Block, T., and Mehta, A. (2010) Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma. PLoS One. 5, e12419
73. Al Bugami, M. M., Farahat, K. L., Al-Ashgar, H. I., and Hainau, B. (2004) Fibrolamellar hepatocellular carcinoma with alpha-one antitrypsin liver disease. Saudi J. Gastroenterol. 10, 92-95
74. Normandin, K., Péant, B., Le Page, C., de Ladurantaye, M., Ouellet, V., Tonin, P. N., Provencher, D. M., and Mes-Masson, A. M. (2010) Protease inhibitor SERPINA1 expression in epithelial ovarian cancer. Clin. Exp. Metastasis 27, 55-69
75. Woźniak, B., Mila-Kierzenkowska, C., Woźniak, A., Drewa, G., Sopońska, M., Drewa, T., Krzyzyńska-Malinowska, E., Makarewicz, R., Kowalski, T., and Szmytkowska, K. (2008) The effect of combined therapy on activity of cathepsin D and alpha-1-antitrypsin in the blood serum of women with cervical cancer. Eur. J. Gynaecol. Oncol. 29, 617-619
76. Scamuffa, N., Siegfried, G., Bontemps, Y., Ma, L., Basak, A., Cherel, G., Calvo, F., Seidah, N. G., and Khatib, A. M. (2008) Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J. Clin. Invest. 118, 352-363
77. Mbeunkui, F., Metge, B. J., Shevde, L. A., and Pannell, L. K. (2007) Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. Proteome Res. 6, 2993-3002 (Pubitemid 47310184)
78. Zelvyte, I., Wallmark, A., Piitulainen, E., Westin, U., and Janciauskiene, S. (2004) Increased plasma levels of serine proteinase inhibitors in lung cancer patients. Anticancer Res. 24, 241-247 (Pubitemid 38279714)
79. Yang, M. H., and Wu, K. J. (2008) TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle. 7, 2090-2096
80. Garber K. (2008) Epithelial-to-mesenchymal transition is important to metastasis, but questions remain. J. Natl. Cancer Inst. 100, 232-239
81. Yang, J., and Weinberg, R.A. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 14, 818-829 (Pubitemid 351757205)
82. Thompson, E. W., and Williams, E. D. (2008) EMT and MET in carcinoma-clinical observations, regulatory pathways and new models. Clin. Exp. Metastasis 25, 591-592
83. Sung, H. J., and Cho, J. Y. (2008) Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep. 41, 615-625
84. Mancini, M., and Toker, A. (2009) NFAT proteins: emerging roles in cancer progression. Nat. Rev. Cancer 9, 810-820
85. Egeblad, M., and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174 (Pubitemid 37328786)
86. Koivunen, J., Aaltonen, V., and Peltonen, J. (2006) Protein kinase C (PKC) family in cancer progression. Cancer Lett. 235, 1-10
87. Nguyen, D. X., Bos, P. D., and Massagué, J. (2009) Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274-284
88. Wong, S. Y., and Hynes, R. O. (2006) Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5, 812-817 (Pubitemid 44149486)
89. Chambers, A. F., Groom, A. C., and MacDonald, I. C. (2002) Dissemination and growth of cancer cells in metastatic sites. Nature Rev. Cancer 2, 563-572 (Pubitemid 37328923)
90. Stenbygaard, L. E., and Sørensen, J. B. (1999) Small bowel metastases in non-small cell lung cancer. Lung Cancer 26, 95-101 (Pubitemid 29492897)
91. Kondo, K., Muramatsu, M., Okamoto, Y., Jin, D., Takai, S., Tanigawa, N., and Miyazaki, M. (2006) Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. J. Surg. Oncol. 93, 36-42 (Pubitemid 43038424)
92. He, S. H., Chen, P., and Chen, H. Q. (2003) Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors. Acta Pharmacol. Sin. 24, 923-929
93. Frank, B. T., Rossall, J. C., Caughey, G. H., and Fang, K. C. (2001) Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by agr-chymase. J. Immunol. 166, 2783-2792 (Pubitemid 32173519)
94. Tchougounova, E., Lundequist, A., Fajardo, I., Winberg, J. O., Abrink, M., and Pejler, G. (2005) A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280, 9291-9296 (Pubitemid 40409621)
95. Eichler, W., Friedrichs, U., Thies, A., Tratz, C., and Wiedemann, P. (2002) Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. Invest. Ophthalmol. Vis. Sci. 43, 2767-2773 (Pubitemid 34809471)
96. Zeidman, I. (1957) Metastasis: a review of recent advances. Cancer Res. 17, 157-162
97. Tarin, D., and Price, J. E. (1981) Influence of microenvironment and vascular anatomy on "metastatic" colonization potential of mammary tumors. Cancer Res. 41, 3604-3609 (Pubitemid 11063644)
98. Hung, T. T., Wu, J. Y., Liu, J. F., and Cheng, H. C. (2009) Epitope analysis of the rat dipeptidyl peptidase IV monoclonal antibody 6A3 that blocks pericellular fibronectin-mediated cancer cell adhesion. FEBS J. 276, 6548-6559
99. Colombi, M., Zoppi, N., De Petro, G., Marchina, E., Gardella, R., Tavian, D., Ferraboli, S., and Barlati, S. (2003) Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide. J. Biol. Chem. 278, 14346-14355 (Pubitemid 36799985)
100. McKeown-Longo, P. J., and Mosher, D. F. (1985) Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts. J. Cell Biol. 100, 364-374
101. Sechler, J. L., and Schwarzbauer, J. E. (1998) Control of cell cycle progression by fibronectin matrix architecture. J. Biol. Chem. 273, 25533-25536 (Pubitemid 28475767)
102. Xu, J., Bae, E., Zhang, Q., Annis, D. S., Erickson, H. P., and Mosher, D. F. (2009) Display of cell surface sites for fibronectin assembly is modulated by cell adherence to (1)F3 and C-terminal modules of fibronectin. PLoS One. 4, e4113
103. Henry, M. D., Satz, J. S., Brakebusch, C., Costell, M., Gustafsson, E., Fässler, R., and Campbell, K. P. (2001) Distinct roles for dystroglycan, beta1 integrin and perlecan in cell surface laminin organization. J. Cell Sci. 114, 1137-1144 (Pubitemid 32288527)
104. Aziz, M. H., Hafeez, B. B., Sand, J. M., Pierce, D. B., Aziz, S. W., Dreckschmidt, N. E., and Verma, A. K. (2010) Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). Oncogene 29, 3100-3109
105. Morgan, K., Marsters, P., Morley, S., van Gent, D., Hejazi, A., Backx, M., Thorpe, E. R., and Kalsheker, N. (2002) Oncostatin M induced alpha1-antitrypsin (AAT) gene expression in Hep G2 cells is mediated by a 3′enhancer. Biochem. J. 365, 555-560 (Pubitemid 36135328)
106. He, S. H., Chen, P., and Chen, H. Q. (2003) Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors. Acta Pharmacol. Sin. 24, 923-929
107. Pat, B., Chen, Y., Killingsworth, C., Gladden, J. D., Shi, K., Zheng, J., Powell, P. C., Walcott, G., Ahmed, M. I., Gupta, H., Desai, R., Wei, C. C., Hase, N., Kobayashi, T., Sabri, A., Granzier, H., Denney, T., Tillson, M., Dillon, A. R., Husain, A., and Dell'italia, L. J. (2010) Chymase inhibition prevents fibronectin and myofibrillar loss and improves cardiomyocyte function and LV torsion angle in dogs with isolated mitral regurgitation. Circulation 122, 1488-1495